Global Heart Failure Academy education on ReachMD

View these accredited e-learning programs with a focus on heart failure at our partner website ReachMD, a leading online learning platform for physicians and other healthcare professionals

Recent

Outcomes, pathophysiology and management of iron deficiency in HF

10' education - Feb. 22, 2022 - Robert Mentz, MD and prof. Peter van der Meer, MD, PhD

Potassium binders as enablers of RAASi therapy in HF

10' education - Feb. 16, 2022 - Prof. Javed Butler, MD and prof. Giuseppe Rosano, MD, PhD

Expert Insights: Managing Patients with CKD, Hyperkalemia, and Continued RAASi Therapy Through a Case Study Approach

Oct. 10, 2021

RAASi Therapy, Diabetes, and Hyperkalemia: Halting Therapy is NOT the Only Option

Oct. 10, 2021

Outcomes, pathophysiology and management of iron deficiency in HF

10' education - Feb. 22, 2022 - Robert Mentz, MD and prof. Peter van der Meer, MD, PhD

Potassium binders as enablers of RAASi therapy in HF

10' education - Feb. 16, 2022 - Prof. Javed Butler, MD and prof. Giuseppe Rosano, MD, PhD

Outcomes, pathophysiology and management of iron deficiency in HF

10' education - Feb. 22, 2022 - Robert Mentz, MD and prof. Peter van der Meer, MD, PhD

Iron deficiency is very common in HF patients, also in patients who are nonanemic. Therefore, you need to measure it and treat it, conclude Robert Mentz and Peter van der Meer.

Potassium binders as enablers of RAASi therapy in HF

10' education - Feb. 16, 2022 - Prof. Javed Butler, MD and prof. Giuseppe Rosano, MD, PhD

Two cardiologists discuss the issue of discontinuation or downtitration of RAASi therapy when hyperkalemia occurs in HF patients and the potential of novel potassium binders in these patients.

Expert Insights: Managing Patients with CKD, Hyperkalemia, and Continued RAASi Therapy Through a Case Study Approach

Faculty: Matthew R. Weir, MD, Gates Colbert, MD, FASN, Robert Toto, MD

Oct. 10, 2021

View this accredited e-learning program with a focus on heart failure at our partner website ReachMD, a leading online learning platform for physicians and other healthcare professionals

RAASi Therapy, Diabetes, and Hyperkalemia: Halting Therapy is NOT the Only Option

Faculty: George L. Bakris, MD, Biff F. Palmer, MD

Oct. 10, 2021

View this accredited e-learning program with a focus on heart failure at our partner website ReachMD, a leading online learning platform for physicians and other healthcare professionals

10' Education

Outcomes, pathophysiology and management of iron deficiency in HF

10' education - Feb. 22, 2022 - Robert Mentz, MD and prof. Peter van der Meer, MD, PhD

Potassium binders as enablers of RAASi therapy in HF

10' education - Feb. 16, 2022 - Prof. Javed Butler, MD and prof. Giuseppe Rosano, MD, PhD